Anesthesia for Pars Plana Vitrectomy (PPV) With Insulin Needle
NCT ID: NCT00735657
Last Updated: 2021-12-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2008-08-31
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Control
needle
Peribulbar blockade with standard (25 mm) needle
Pars Plana Vitrectomy
Peribulbar block
Group 2
Block with short needle
needle
Peribulbar blockade with short (12.5 mm) needle
Pars Plana Vitrectomy
Peribulbar block
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
needle
Peribulbar blockade with standard (25 mm) needle
needle
Peribulbar blockade with short (12.5 mm) needle
Pars Plana Vitrectomy
Peribulbar block
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* With local sepsis
* Serious impairment of coagulation
* Orbital abnormalities
* Unable to cooperate in maintaining a relatively motionless supine position
* Who refused the anesthetic technique
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
King Khaled Eye Specialist Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Waleed Riad, MD
Role: PRINCIPAL_INVESTIGATOR
KKESH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
King Khaled Eye Specialist hospital
Riyadh, , Saudi Arabia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Rp0822
Identifier Type: -
Identifier Source: org_study_id